The future of cassava in the era of biotechnology in Southern Africa
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Otun, Sarah
- dc.contributor.author Escrich Montañana, Ainoa
- dc.contributor.author Achilonu, Ikechukwu
- dc.contributor.author Rauwane, Molemi
- dc.contributor.author Lerma-Escalera, Jordy Alexis
- dc.contributor.author Morones-Ramírez, José Rubén
- dc.contributor.author Rios-Solis, Leonardo
- dc.date.accessioned 2023-09-13T07:11:37Z
- dc.date.available 2023-09-13T07:11:37Z
- dc.date.issued 2023
- dc.description.abstract Cassava (Manihot esculenta) is a major staple food and the world's fourth source of calories. Biotechnological contributions to enhancing this crop, its advances, and present issues must be assessed regularly. Functional genomics, genomic-assisted breeding, molecular tools, and genome editing technologies, among other biotechnological approaches, have helped improve the potential of economically important crops like cassava by addressing some of its significant constraints, such as nutrient deficiency, toxicity, poor starch quality, disease susceptibility, low yield capacity, and postharvest deterioration. However, the development, improvement, and subsequent acceptance of the improved cultivars have been challenging and have required holistic approaches to solving them. This article provides an update of trends and gaps in cassava biotechnology, reviewing the relevant strategies used to improve cassava crops and highlighting the potential risk and acceptability of improved cultivars in Southern Africa.
- dc.format.mimetype application/pdf
- dc.identifier.citation Otun S, Escrich A, Achilonu I, Rauwane M, Lerma-Escalera JA, Morones-Ramírez JR, Rios-Solis L. The future of cassava in the era of biotechnology in Southern Africa. Crit Rev Biotechnol. 2023;43(4):594-612. DOI: 10.1080/07388551.2022.2048791
- dc.identifier.doi http://dx.doi.org/10.1080/07388551.2022.2048791
- dc.identifier.issn 0738-8551
- dc.identifier.uri http://hdl.handle.net/10230/57854
- dc.language.iso eng
- dc.publisher Taylor & Francis
- dc.relation.ispartof Crit Rev Biotechnol. 2023;43(4):594-612
- dc.rights © 2022 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/bync-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/bync-nd/4.0/
- dc.subject.keyword Biofortification
- dc.subject.keyword CRISPR/Cas9
- dc.subject.keyword Manihot esculenta
- dc.subject.keyword Biosafety
- dc.subject.keyword Biotechnology
- dc.subject.keyword Cassava mosaic disease
- dc.subject.keyword Cyanogen glycoside
- dc.subject.keyword Genome editing
- dc.subject.keyword Post-harvest deterioration
- dc.title The future of cassava in the era of biotechnology in Southern Africa
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion